ALG14 Antibody (Center) Blocking Peptide
€363.00
In stock
SKU
AC-BP8903c
Background:
ALG14 is involved in protein N-glycosylation. It is essential for the second step of the dolichol-linked oligosaccharide pathway. It anchors the catalytic subunit ALG13 to the ER.
Other Names:
UDP-N-acetylglucosamine transferase subunit ALG14 homolog, ALG14
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP8903c was selected from the Center region of human ALG14. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: ALG14 (HGNC:28287)
Gene ID: 199857
Primary Accession: Q96F25
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
ALG14 is involved in protein N-glycosylation. It is essential for the second step of the dolichol-linked oligosaccharide pathway. It anchors the catalytic subunit ALG13 to the ER.
Other Names:
UDP-N-acetylglucosamine transferase subunit ALG14 homolog, ALG14
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP8903c was selected from the Center region of human ALG14. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: ALG14 (HGNC:28287)
Gene ID: 199857
Primary Accession: Q96F25
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review